⌘K

Login Start Free

Home/Filings/4/0001628280-25-034160

4//SEC Filing

Shahbazi Hamed 4

Accession 0001628280-25-034160

CIK 0001386570other

View on SEC.gov Company Profile

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 10:42 AM ET

Size

5.4 KB

Accession

0001628280-25-034160

Insider Transaction Report

Form 4

Period: 2025-06-24

Niagen Bioscience, Inc.NAGE

Director

Transactions

Award
Stock Option (right to buy)
2025-06-24+20,000→ 20,000 total
Exercise: $14.13From: 2026-06-24Exp: 2035-06-23→ Common Stock (20,000 underlying)

Footnotes (1)

[F1]Option vests 100% on June 24, 2026.

Documents

1 file

4
wk-form4_1751553733.xmlPrimary
FORM 4

Issuer

Niagen Bioscience, Inc.

CIK 0001386570

Entity typeother

Related Parties

1

filerCIK 0001942711

Filing Metadata

Form type: 4
Filed: Jul 2, 8:00 PM ET
Accepted: Jul 3, 10:42 AM ET
Size: 5.4 KB

View on SEC.gov